A carregar...
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown to enhance the therapeutic effects of cancer chemotherapy and also to enhance...
Na minha lista:
| Publicado no: | Asian Pac J Cancer Prev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
West Asia Organization for Cancer Prevention
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982677/ https://ncbi.nlm.nih.gov/pubmed/31653148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.3007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|